TheLRRK2Gly2385Arg variant is associated with Parkinson’s disease: genetic and functional evidence
✍ Scribed by E. K. Tan; Y. Zhao; L. Skipper; M. G. Tan; A. Di Fonzo; L. Sun; S. Fook-Chong; S. Tang; E. Chua; Y. Yuen; L. Tan; R. Pavanni; M. C. Wong; P. Kolatkar; C. S. Lu; V. Bonifati; J. J. Liu
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 324 KB
- Volume
- 120
- Category
- Article
- ISSN
- 0340-6717
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract We conducted a case–control study to determine the prevalence of the __LRRK2__ Gly2385Arg variant in patients with Parkinson's disease in Han population in mainland China. Heterozygous __LRRK2__ Gly2385Arg variant was identified in 14 of 235 patients with Parkinson's disease (5.69%), bu
## Abstract Patients with Parkinson's disease (PD) may have hippocampal atrophy compared with controls. We compared hippocampal, and extra‐hippocampal volumes between PD, PDD (patients with PD who have mild cognitive impairment or dementia), Alzheimer's disease (AD) and controls using volumetric ma
Nonalcoholic fatty liver disease (NAFLD) is a burgeoning medical problem that affects 20%-34% of the population in Western countries. 1 Although the prevalence of NAFLD is somewhat lower in Asia, the frequency is increasing, and the disorder is now being seen in younger individuals. 2,3 NAFLD is a m